ICD E75.02ORPHA:845TSD

Tay-Sachs Disease

Tay-Sachs Disease is a rare inherited lysosomal storage disorder caused by mutations in the HEXA gene, resulting in the toxic accumulation of gangliosides in nerve cells. The infantile form is typically fatal by age 5; late-onset forms present in adolescence or adulthood. Carrier screening in at-risk populations (Ashkenazi Jewish, French-Canadian) has dramatically reduced incidence.

295
Articles
26
Trials (2 AU)
Updated
5 April 2026
Loading...

Common Questions

What is Tay-Sachs Disease?

Tay-Sachs Disease is a rare inherited lysosomal storage disorder caused by mutations in the HEXA gene, resulting in the toxic accumulation of gangliosides in nerve cells. The infantile form is typically fatal by age 5; late-onset forms present in adolescence or adulthood. Carrier screening in at-risk populations (Ashkenazi Jewish, French-Canadian) has dramatically reduced incidence.

How many clinical trials are available for Tay-Sachs Disease?

RareWays currently indexes 26 clinical trials for Tay-Sachs Disease, of which 8 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.

Where does the research data for Tay-Sachs Disease come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Tay-Sachs Disease.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.